Urocit‑K

Before taking this medicine

Do not take Urocit-K if you have high blood potassium or a condition that increases this risk, including chronic kidney failure, uncontrolled diabetes, acute dehydration, adrenal insufficiency or extensive tissue breakdown. Strenuous exercise when you are not physically conditioned can also increase this risk. Do not take it with potassium-sparing medicines such as triamterene, spironolactone or amiloride. Urocit-K must not be used if you have: • Delayed or blocked tablet passage through the digestive tract, including delayed stomach emptying, compression of the oesophagus, or a narrowed or blocked intestine; this also applies if you take anticholinergic medicines. • Peptic ulcer disease. • An active urinary tract infection. • Reduced kidney function with a glomerular filtration rate below 0.7 mL/kg/min. Avoid Urocit-K if you have a condition that prevents your body from removing potassium properly, including severe heart muscle damage or heart failure. Dangerously high potassium can develop quickly without symptoms and may cause cardiac arrest. Monitoring includes periodic blood tests and ECGs. Stop taking Urocit-K immediately and seek medical assessment if you develop severe vomiting, abdominal pain or bleeding from the digestive tract. These symptoms require investigation for a bowel blockage or perforation. During pregnancy or breastfeeding, Urocit-K should be used only if clearly needed. Its effects on an unborn baby, reproductive capacity and the potassium content of breast milk are unknown. Safety and effectiveness in children have not been established.